Targeting Epac2 and GluA3-containing AMPARs: a novel therapeutic strategy for Alzheimer’s disease
Saved in:
Main Authors: | Tong Zhang, Martina Schmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-11-01
|
Series: | Neural Regeneration Research |
Online Access: | https://journals.lww.com/10.4103/NRR.NRR-D-24-00751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emotional stress increases GluA2 expression and potentiates fear memory via adenylyl cyclase 5
by: Qian Yang, et al.
Published: (2025-01-01) -
Female mice lacking GluA3 show early onset of hearing loss, cochlear synaptopathy, and afferent terminal swellings in ambient sound levels
by: Indra Pal, et al.
Published: (2025-02-01) -
Epac1 Restores Normal Insulin Signaling through a Reduction in Inflammatory Cytokines
by: Elizabeth Curtiss, et al.
Published: (2018-01-01) -
Small-Cell Lung Cancer with Positive Anti-NMDAR and Anti-AMPAR Antibodies Paraneoplastic Limbic Encephalitis
by: Sabina Boangher, et al.
Published: (2016-01-01) -
Gluing for the Einstein constraint equations
by: Corvino, Justin
Published: (2025-01-01)